IBIO-200
/ iBio, CC-Pharming, Infectious Disease Research Institute
- LARVOL DELTA
Home
Next
Prev
1 to 20
Of
20
Go to page
1
January 25, 2024
An Open One-Step RT-qPCR for SARS-CoV-2 detection.
(PubMed, PLoS One)
- "The COVID-19 pandemic has resulted in millions of deaths globally, and while several diagnostic systems were proposed, real-time reverse transcription polymerase chain reaction (RT-PCR) remains the gold standard...Further evaluation on 40 clinical samples (20 positive and 20 negative) confirmed its comparable diagnostic accuracy. This study represents a proof of concept for an open approach to developing diagnostic kits for viral infections and diseases, which could provide a cost-effective and accessible solution for less developed countries."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
July 30, 2022
Prediabetes Induces More Severe Acute COVID-19 Associated With IL-6 Production Without Worsening Long-Term Symptoms.
(PubMed, Front Endocrinol (Lausanne))
- "PDM seems to be associated with increased risk of severe COVID-19, as well as higher serum levels of IL-6, which may constitute a potential biomarker of severe COVID-19 risk in affected patients. Furthermore, while PDM correlated with more severe acute-phase COVID-19, no long-term worsening of sequelae was observed."
Journal • Cardiovascular • Critical care • Genetic Disorders • Hypertension • Immunology • Infectious Disease • Inflammation • Metabolic Disorders • Novel Coronavirus Disease • Obesity • IL6
June 28, 2022
Impacts of the COVID-19 pandemic restrictions on solid waste pollution in the worldwide iconic Copacabana Beach (Rio de Janeiro, Brazil).
(PubMed, Mar Pollut Bull)
- "Qualitative data revealed that most of solid wastes were single-use plastics recently disposed at Copacabana beach, reflecting beachgoer's effects on waste left on the beach. A positive impact of COVID-19 pandemic restrictions was detected on solid waste pollution at Copacabana beach."
Journal • Infectious Disease • Novel Coronavirus Disease
February 10, 2022
Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications.
(PubMed, J Biomol Tech)
- "As the second year of the COVID-19 pandemic begins, it remains clear that a massive increase in the ability to test for SARS-CoV-2 infections in a myriad of settings is critical to controlling the pandemic and to preparing for future outbreaks...The final discussion section provides the reader with a distillation of the most validated testing methods and their paths to implementation. This review also aims to provide practical information and insight for a range of audiences: for a research audience, to help accelerate research through sharing of best practices; for an implementation audience, to help get testing up and running quickly; and for a public health, clinical, and policy audience, to help convey the breadth of the effect that LAMP methods have to offer."
Journal • Review • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
January 15, 2022
Homebrew reagents for low-cost RT-LAMP.
(PubMed, J Biomol Tech)
- "Reverse transcription-loop-mediated isothermal amplification (RT-LAMP) has gained popularity for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...The in-house preparation of these reactions results in an order of magnitude reduction in costs; thus, we provide protocols and DNA to enable the replication of these tests at other locations. These results contribute to the global effort of developing open and low-cost diagnostics that enable technological autonomy and distributed capacities in viral surveillance."
Journal • Hematological Malignancies • Infectious Disease • Leukemia • Novel Coronavirus Disease • Oncology • Respiratory Diseases
May 01, 2021
Accessible LAMP-Enabled Rapid Test (ALERT) for Detecting SARS-CoV-2.
(PubMed, Viruses)
- "ALERT (Accessible LAMP-Enabled Rapid Test) incorporates the following features: (1) increased shelf-life and ambient temperature storage, compared to liquid reaction mixes, by using wax layers to isolate enzymes from other reagents; (2) improved specificity compared to other LAMP end-point reporting methods, by using sequence-specific QUASR (quenching of unincorporated amplification signal reporters); (3) increased sensitivity, compared to methods without purification through use of a magnetic wand to enable pipette-free concentration of sample RNA and cell debris removal; (4) quality control with a nasopharyngeal-specific mRNA target; and (5) co-detection of other respiratory viruses, such as influenza B, by multiplexing QUASR-modified RT-LAMP primer sets. The flexible nature of the ALERT workflow allows easy, at-home and point-of-care testing for individuals and higher-throughput processing for labs and hospitals. With minimal effort, severe acute respiratory syndrome..."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • PCR
November 29, 2020
"My Three Biotech Covid-19 Stocks: Inovio Pharmaceuticals (INO), iBio (IBIO), and VBI Vaccines (VBIV) https://t.co/TguUozFZH5"
(@alliseeis_W)
Infectious Disease • Novel Coronavirus Disease
July 30, 2020
"100 Followers. So it begins. $IBIO @SCClemons @infusedlights @PeterHotez @HHS_ASH @IBMWatson #coronavirus #COVID19 #Vegan $IBIO @DARPA @ibiobagger @peterprimamore"
(@IBIOIBMDARPA)
Infectious Disease • Novel Coronavirus Disease
April 05, 2020
"#エーザイ は #COVID19 に対する医薬品等を世界中に届けることをめざすゲイツ財団@gatesfoundation のコンソーシアムに世界の製薬企業15社の1つとして参画しています。 この取り組みについて、日経バイオテク @nikkeibiotech に記事が掲載されました。 #新型コロナウイルス https://t.co/Gi8giOSGc0"
(@Eisai_SDGs)
April 02, 2020
"Coronavirus can cause pneumonia, you do need antibiotics to treat pneumonia..."
(@julia13_julia13)
April 01, 2020
"Antibiotics can not and do not treat #COVID19. Antibiotics only work against bacteria. #COVID19 is a virus. @KITETrainees @TRI_UHN"
(@MilosRPopovic)
April 02, 2020
"MYTH: Antibiotics can prevent and treat #COVID19. #KnowTheFacts"
(@SanofiUS)
March 28, 2020
"As My opinion on Pandemic (Coronavirus) treatment, in antibiotics, Levofloxacin is Effective!"
(@sakagami_koji)
March 16, 2020
"Insights from @DHpharmd @jasonroberts_pk @emilylheil @julie_justo @IDstewardship @davidantibiotic @syctong @IDPharmacometrx @MattDavis138 @ConanMacDougall #COVID19 #COVID19RX"
(@ABsteward)
March 22, 2020
"Is it resistant to antibiotics? 🤔 #COVID19"
(@SolidGraniteNH)
March 16, 2020
"@davidantibiotic Are u find it vacinne of coronavirus?"
(@mhmmdgaziavci)
March 17, 2020
Innovation Pharmaceuticals brilacidin to be researched as possible novel coronavirus (COVID-19) vaccine; brilacidin now being tested as drug and vaccine at different institutions
(GlobeNewswire, Innovation Pharmaceuticals Inc.)
- “Innovation Pharmaceuticals…announced further details on the Material Transfer Agreement (MTA) signed with a leading public health-focused U.S. university and top coronavirus expert. Under the terms of the confidential agreement, virologists plan to evaluate the potential antiviral properties of Brilacidin, the Company’s lead defensin-mimetic drug candidate, toward developing Brilacidin as a potential novel coronavirus (COVID-19) vaccine…This new research is independent of that being conducted on Brilacidin at one of the U.S. 12 Regional Biocontainment Labs (RBL).”
Clinical • Licensing / partnership
March 16, 2020
"Coronavirus treatment will be Antihistamines+paracetamol & needed prophylactic antibiotics"
(@idreeszazai)
March 20, 2020
"Are antibiotics effective in preventing or treating COVID-19?"
(@pfizer)
March 17, 2020
"…primarily antivirals thought to reduce the impact of coronavirus and antibiotics to combat pneumonia. 5/8"
(@NovartisNews)
1 to 20
Of
20
Go to page
1